David J. Shuster

3.5k citations

29 papers · 1.6k indexed · h-index 19

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Immunology top 5%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Immunology and Allergy 5
- Cell Adhesion Molecules Research 4
Immunology 16
- Immune Response and Inflammation 8
- Immune Cell Function and Interaction 5

Co-authors: Kim W. McIntyre Mark Labow Kathleen M. Gillooly Emily B. Cullinan R Chizzonite Tamás Bartfai Maria Zetterström Carmen C. Solórzano
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Medicinal Chemistry (5 papers)The Journal of Immunology (3 papers)Bioanalysis (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Germany Japan

In The Last Decade

David J. Shuster

29 papers receiving 1.6k citations

Peers

Countries citing papers authored by David J. Shuster

Since Specialization

Citations

This map shows the geographic impact of David J. Shuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Shuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Shuster more than expected).

Fields of papers citing papers by David J. Shuster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Shuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Shuster. The network helps show where David J. Shuster may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David J. Shuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Shuster Line = papers co-authored together David J. Shuster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid Drug Metabolism and Disposition ·Yueping Zhang, Shen-Jue Chen, Cliff Chen, Xueqing Chen, Sagnik Chatterjee, David J. Shuster, 小田哲子, Laura E. Armstrong, Elizabeth Joshi, Zheng Yang, Hong Shen	2022	4
2	Absence of OATP1B (Organic Anion–Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression Journal of Pharmacology and Experimental Therapeutics ·Yueping Zhang, Cliff Chen, Shen-Jue Chen, Xueqing Chen, David J. Shuster, S Iswarya, Ram Alpana, Zheng Yang, Michael Sinz, Hong Shen	2020	8
3	Improving the Pharmacokinetic and CYP Inhibition Profiles of Azaxanthene-Based Glucocorticoid Receptor Modulators—Identification of (S)-5-(2-(9-Fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341) Journal of Medicinal Chemistry ·Michael G. Yang, T. G. Murali Dhar, Zili Xiao, Hai‐Yun Xiao, James J.‐W. Duan, Bin Jiang, Michael A. Galella, Mark Cunningham, Jinhong Wang, E. SIEVERS, David J. Shuster, Kim W. McIntyre, Julie Carman, P.. Domia, John E. Somerville, Steven G. Nadler, Luisa Salter–Cid, Joel C. Barrish, David S. Weinstein	2015	11
4	Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists Bioorganic & Medicinal Chemistry Letters ·Hua Gong, Michael G. Yang, Zili Xiao, Arthur M. Doweyko, Mark Cunningham, Jinhong Wang, E. SIEVERS, P.. Domia, Christine Burke, David J. Shuster, Michael Ryon, Julie Carman, John E. Somerville, Steven G. Nadler, Luisa Salter–Cid, Joel C. Barrish, David S. Weinstein	2014	12
5	Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: Practical considerations in assay development and validation Journal of Chromatography A ·Guowen Liu, Qin Ji, Robert Dodge, Huadong Sun, David J. Shuster, Qihong Zhao, Mark E. Arnold	2013	28
6	Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Alaric J. Dyckman, Tianle Li, Sidney Pitt, Rosemary Zhang, Ding Ren Shen, Kim W. McIntyre, Kathleen M. Gillooly, David J. Shuster, Arthur M. Doweyko, John S. Sack, Kevin Kish, Susan E. Kiefer, John A. Newitt, Hongjian Zhang, Punit H. Marathe, Murray McKinnon, Joel C. Barrish, John H. Dodd, Gary L. Schieven, Katerina Leftheris	2011	9
7	An LFA-1 (αLβ2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis The Journal of Immunology ·Suzanne J. Suchard, Dawn K. Stetsko, Patricia M. Davis, Stacey Skala, Dominique Potin, N. Satcitta, T. G. Murali Dhar, Joel C. Barrish, Vojkan Susulic, David J. Shuster, Kim W. McIntyre, Murray McKinnon, Luisa Salter–Cid	2010	30
8	Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Stephen T. Wrobleski, Shuqun Lin, John Hynes, Hong Wu, Sidney Pitt, Ding Ren Shen, Rosemary Zhang, Kathleen M. Gillooly, David J. Shuster, Kim W. McIntyre, Arthur M. Doweyko, Kevin Kish, Jeffrey Tredup, Gerald J. Duke, John S. Sack, Murray McKinnon, John H. Dodd, Joel C. Barrish, Gary L. Schieven, Katerina Leftheris	2008	25
9	Creation and Characterization of E‐Selectin‐ and VCAM‐1‐Deficient Mice Novartis Foundation symposium ·Lia Kwee, Daniel K. Burns, John M. Rumberger, N. S. Malyavkina, Barry A. Wolitzky, Robert Terry, Joshua Kong Yang, David J. Shuster, Frank Köntgen, Colin L. Stewart, Kim W. McIntyre, H. Scott Baldwin, Mark Labow	2007	5
10	Assessment of tissue biomarkers following anti-CD137 treatment in the EMT-6 mouse tumor model. Cancer Research ·Zenta Tsuchihashi, Ines Brautzsch, M.V.D.L. Sathyanarayana, Anne Lewin, David J. Shuster, Curtis, Shujian Wu, Maria Jure‐Kunkel	2006	2
11	Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, NielsonFlemming, Chunjian Liu, Robert V. Moquin, James C. Lin, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Valentin Ojeda, Arthur M. Doweyko, Amrita V. Kamath, Hongjian Zhang, Punit Marathe, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	64
12	Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors Bioorganic & Medicinal Chemistry Letters ·Jagabandhu Das, Chunjian Liu, Robert V. Moquin, James C. Lin, NielsonFlemming, Steven H. Spergel, Kim W. McIntyre, David J. Shuster, Kathleen O'Day, Becky Penhallow, Ippolito Camele, Steven B. Kanner, Tai-An Lin, John H. Dodd, Joel C. Barrish, John Wityak	2006	31
13	A HIGHLY SELECTIVE INHIBITOR OF IκB KINASE, BMS-345541, AUGMENTS GRAFT SURVIVAL MEDIATED BY SUBOPTIMAL IMMUNOSUPPRESSION IN A MURINE MODEL OF CARDIAC GRAFT REJECTION Transplantation ·A Rutkowski, Jennifer Postelnek, Vojkan Susulic, Kim W. McIntyre, David J. Shuster, Yuping Qiu, F. Christopher Zusi, James R. Burke	2004	20
14	Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors Bioorganic & Medicinal Chemistry Letters ·Ping Chen, Derek Norris, Jagabandhu Das, Steven H. Spergel, John Wityak, Leslie Leith, Rui-Lin Zhao, Bang‐Chi Chen, Sidney Pitt, Suhong Pang, Ding Ren Shen, Rosemary Zhang, H. Fex, Arthur M. Doweyko, Kim W. McIntyre, David J. Shuster, Kamelia Behnia, Gary L. Schieven, Joel C. Barrish	2004	22
15	A highly selective inhibitor of IκB kinase, BMS‐345541, blocks both joint inflammation and destruction in collagen‐induced arthritis in mice Arthritis & Rheumatism ·Kim W. McIntyre, David J. Shuster, Kathleen M. Gillooly, Donna M. Dambach, Mark A. Pattoli, О Т Єлізарова, Xiadi Zhou, Yuping Qiu, F. Christopher Zusi, James R. Burke	2003	185
16	C-3 Amido-Indole cannabinoid receptor modulators Bioorganic & Medicinal Chemistry Letters ·John Hynes, Katerina Leftheris, Wu Hong, Chennagiri R. Pandit, Ping Chen, Derek Norris, Bang‐Chi Chen, Rui-Lin Zhao, Peter A. Kiener, Xiaorong Chen, V. A. Kimasov, S.M. Pryshchepa, Kathleen M. Gillooly, David J. Shuster, Kim W. McIntyre	2002	28
17	Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice The Journal of Immunology ·Mark Labow, David J. Shuster, Maria Zetterström, Priscila Rezeck Nunes, Rachael Terry, Emily B. Cullinan, Tamás Bartfai, Carmen C. Solórzano, Lyle L. Moldawer, R Chizzonite, Kim W. McIntyre	1997	286
18	Reduced incidence and severity of collagen‐induced arthritis in interleukin‐12‐deficient mice European Journal of Immunology ·Kim W. McIntyre, David J. Shuster, Kathleen M. Gillooly, Rajeev R. Warrier, Suzanne E. Connaughton, Al-Zamil Alhanouf, L. H. Arp, Maurice K. Gately, Jeanne Magram	1996	152
19	Insertion of a Structural Domain of Interleukin (IL)-1β Confers Agonist Activity to the IL-1 Receptor Antagonist Journal of Biological Chemistry ·Scott Greenfeder, 大西正俊, Gordon Powers, K. Kobanawa, David J. Shuster, Kim W. McIntyre, Dene E. Ryan, Wayne Levin, Vincent Madison, G Ju	1995	26
20	Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins Immunity ·Mark Labow, Christine R. Norton, John M. Rumberger, Joshua Kong Yang, David J. Shuster, Jennifer Hubbard, Jacques Crépet, Jumrohtul Wahda, Robert W. Terry, Margaret L. Harbison, Frank Köntgen, Colin L. Stewart, Kim W. McIntyre, Peter C. Will, Daniel K. Burns, Barry A. Wolitzky	1994	318

About David J. Shuster

David J. Shuster is a scholar working on Immunology and Allergy, Immunology, Oncology, Pharmacology and Cancer Research, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Melanoma and MAPK Pathways (4 papers), Estrogen and related hormone effects (4 papers), Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Immunology and Allergy (318 citations), Immunology (749 citations), Cancer Research (206 citations), Toxicology (39 citations) and Oncology (297 citations). David J. Shuster has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Kim W. McIntyre, Mark Labow, Kathleen M. Gillooly, Emily B. Cullinan, R Chizzonite, Tamás Bartfai, Maria Zetterström, Carmen C. Solórzano, Lyle L. Moldawer and Priscila Rezeck Nunes. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Immunology, Bioanalysis and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact